PCM Trials Acquires EmVenio Research to Create the Most Patient-Centric Model for Hybrid and Decentralized Clinical Trials
Acquiring Company
PCM Trials
Acquired Company
Emvenio Research
Description
Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), has announced the acquisition of EmVenio Research based in Durham, North Carolina. This acquisition strengthens PCM Trials' and EmVenio's abilities to recruit and retain diverse populations for clinical research studies, as required for regulatory approval.
Quick answer
PCM Trials is acquiring Emvenio Research, announced February 23, 2024. PCM Trials is based in Denver, Colorado, United States.
- How much did PCM Trials pay for Emvenio Research?
- The deal value was not disclosed.
- What does PCM Trials do?
- PCM Trials is leading the way in mobile research and decentralized clinical trials.
- Where are PCM Trials and Emvenio Research based?
- PCM Trials is based in Denver, Colorado, United States. Emvenio Research is based in Durham, North Carolina, United States.
- Who are the decision-makers at PCM Trials?
- Fundz holds 1 contact at PCM Trials. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Market Research and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Apollo Intelligence, a Frazier Healthcare Portfolio Company, Acquires GlocalMind, Expanding its Global Reach and Operations in Healthcare and Life Science Market Insights (February 20, 2024)
- New Project Media Acquires Energy Rev, Announces Expansion Into Europe (January 9, 2024)
- CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities (April 8, 2024)
- Smart for Life to acquire Purely Optimal Nutrition to strengthen its position in Health & Wellness sector (April 8, 2024)
- Johnson & Johnson completes acquisition of Shockwave Medical, Inc. to expand its presence in cardiovascular intervention (April 5, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
Who to call at PCM Trials, and when
When PCM Trials changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day PCM Trials raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PCM Trials, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PCM Trials. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PCM Trials makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Emvenio Research?
Emvenio Research was acquired by PCM Trials, based in Denver. The deal was reported on February 23, 2024. PCM Trials is leading the way in mobile research and decentralized clinical trials. Since 2008, PCM Trials has led the way in mobile research. PCM Trials is privately held and operates in Market Research.
When did PCM Trials acquire Emvenio Research?
PCM Trials's acquisition of Emvenio Research was reported on February 23, 2024. Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), has announced the acquisition of EmVenio Research based in Durham, North Carolina. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Emvenio Research do?
EmVenio Research offers a network of Community Research Sites (CRS) located in underrepresented communities to better reach difficult-to-reach and diverse patient populations. It is privately held, operating in Healthcare, and is based in Durham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.